Understanding the Impact of the Veradigm Network on Value-Based Healthcare Delivery


Amanda Cohen

Amanda Cohen

As healthcare is moving toward the shared goal of improving patient care more economically, stakeholders across the spectrum are increasingly aligned with the principles of value-based care. This paradigm shift is particularly evident in biopharma, which plays a pivotal role in the American healthcare system’s transformation. As we navigate this transition, the complexity of healthcare decision-making escalates, challenging providers to balance high-quality, cost-effective, and patient-centric care.

Healthcare professionals are often tasked with choosing from a variety of treatment options, including biopharmaceuticals, medical devices, and healthcare services. The evaluation of these options is complex, as they present a broad spectrum of economic and clinical costs and benefits. Some of these factors are quantifiable, while others, such as patient-experienced benefits, may not be immediately apparent.

Veradigm stands at the intersection of the healthcare industry’s key stakeholders: providers, payers, and biopharma companies. The Veradigm Network enables biopharma, and other key healthcare stakeholders, to unlock value in ways that were previously unattainable.

What is the Veradigm Network?

Some healthcare companies provide clinical data, others deliver insights through data analysis, while others serve healthcare providers directly by providing software at the point-of-care.

Veradigm does it all, via the Veradigm Network. Veradigm’s scale, analytic capabilities, and workflow connectivity drive efficiencies for its clients and enhance decision making with insights derived directly from the point of patient care. Veradigm’s open, connected network of solutions and partners is well-positioned to serve life science organizations in a way that meets the needs of today’s connected healthcare ecosystem.

Veradigm Network Advantage

Through the Veradigm Network, biopharma and other life science organizations have access to expansive de-identified ambulatory electronic health record (EHR) data and insights. Veradigm’s portfolio of connected solutions can help you discover timely, actionable real-world evidence to demonstrate how your products can benefit appropriate patient populations. 

The Veradigm Network is built upon Veradigm’s comprehensive healthcare provider footprint, which combines data from both its owned EHRs and EHR collaborators. Because Veradigm is the source of the data itself, Veradigm can help you uncover otherwise hard-to-find insights derived at the point-of-care.

Connected Solutions for Biopharma

Veradigm’s solution portfolio designed for biopharma provides expansive de-identified ambulatory patient insights from the point-of-care and delivers enhanced access to clinical research opportunities.

  • Veradigm Network EHR Data: Deidentified real world data from an extensive national population of patients drawn from community-based physician practice—where most of the care and patient record generation happens in the United States
  • Veradigm Cardiology Registry: Cardiology’s largest outpatient quality improvement registry, capturing data on coronary artery disease, hypertension, heart failure and atrial fibrillation
  • Veradigm Metabolic Registry: The first clinical ambulatory registry aimed at tracking and improving the quality of diabetes and cardiometabolic care
  • Real World Evidence: Data and platform enabled research services, capturing the full spectrum of real-world evidence (RWE) generation, including prospective and retrospective studies, safety surveillance, and more
  • Veradigm Digital Health Media: Highly targeted awareness messaging via the practice workflow in the physician’s EHR system

By integrating data analytics, clinical insights, and a comprehensive network of healthcare providers, Veradigm is uniquely positioned to support biopharma in its transition towards more patient-centered, cost-effective care. The Veradigm Network’s ability to provide de-identified EHR data and real-world evidence empowers stakeholders to make informed decisions that benefit both patients and the healthcare system at large.

Related Content
© 2024 MJH Life Sciences

All rights reserved.